Referências
Brasil. Ministério da Saúde Instituto Nacional do Câncer – INCA. Estimativa 2010 [Internet]. [acesso em 2012 set 26]. Disponível em: [www.inca.gov.br/estimativa/2010].
Beerman H, van Dorst EBL, Kuenen-Boumeester V, Hogendoorn PC. Superior performance of liquid-based versus conventional cytologic in a population-based cervical cancer screening program. Gynecol Oncol. 2009 mar;112(3):572-6.
Fremont-Smith M, Marino J, Griffin B, Spencer L, Bolick D. Comparison of the SurePath liquid-based Papanicolaou smear with the conventional Papanicolaou smear in a multisite direct-to-vial study. Cancer. 2004 out 25;102(5):269-79.
Siebers AG, Klinkhamer PJJM, Grefte JMM, Massuger LFAG, Vedder JEM, Beijers-Broos A, Bulten J, Arbyn M. Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors- a randomized controlled trial. JAMA. 2009 out 28;302(16):1757-64